These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12836301)

  • 1. Transfection of fluorescent probed antisense compounds: L-cysteine derivatives of nucleic acid bases.
    Kitaoka S; Inaki Y; Maruoka H; Tohnai N; Hatae T; Tanabe T
    Nucleic Acids Res Suppl; 2001; (1):135-6. PubMed ID: 12836301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study about the inhibition of L-cysteine derivatives of nucleic acid bases in protein production.
    Maruoka H; Kitaoka S; Tohnai N; Inaki Y; Tanabe T
    Nucleic Acids Res Suppl; 2001; (1):97-8. PubMed ID: 12836282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts.
    Scherr M; Rossi JJ
    Nucleic Acids Res; 1998 Nov; 26(22):5079-85. PubMed ID: 9801303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA.
    Frieden M; Christensen SM; Mikkelsen ND; Rosenbohm C; Thrue CA; Westergaard M; Hansen HF; Ørum H; Koch T
    Nucleic Acids Res; 2003 Nov; 31(21):6365-72. PubMed ID: 14576324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent probe and permeability to cells of isopoly (S-carboxymethyl-L-cysteine) derivative of nucleic acid bases.
    Kitaoka S; Tohnai N; Inaki Y; Hatae T; Tanabe T
    Nucleic Acids Symp Ser; 1999; (42):91-2. PubMed ID: 10780394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.
    Wahlestedt C; Salmi P; Good L; Kela J; Johnsson T; Hökfelt T; Broberger C; Porreca F; Lai J; Ren K; Ossipov M; Koshkin A; Jakobsen N; Skouv J; Oerum H; Jacobsen MH; Wengel J
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5633-8. PubMed ID: 10805816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ribonuclease H-oligo DNA conjugate that specifically cleaves hepatitis B viral messenger RNA.
    Walton CM; Wu CH; Wu GY
    Bioconjug Chem; 2001; 12(5):770-5. PubMed ID: 11562195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the RNase H cleavage kinetics and blood serum stability of the north-conformationally constrained and 2'-alkoxy modified oligonucleotides.
    Honcharenko D; Barman J; Varghese OP; Chattopadhyaya J
    Biochemistry; 2007 May; 46(19):5635-46. PubMed ID: 17411072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the inhibition of protein production by L-cysteine derivatives of nucleic acid bases.
    Inaki Y; Maruoka H
    Nucleic Acids Res Suppl; 2002; (2):103-4. PubMed ID: 12903126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New candidates for true antisense.
    Toulmé JJ
    Nat Biotechnol; 2001 Jan; 19(1):17-8. PubMed ID: 11135542
    [No Abstract]   [Full Text] [Related]  

  • 11. Photoregulating RNA digestion using azobenzene linked dumbbell antisense oligodeoxynucleotides.
    Wu L; He Y; Tang X
    Bioconjug Chem; 2015 Jun; 26(6):1070-9. PubMed ID: 25961679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo.
    Sohail M; Hochegger H; Klotzbücher A; Guellec RL; Hunt T; Southern EM
    Nucleic Acids Res; 2001 May; 29(10):2041-51. PubMed ID: 11353073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligodeoxynucleotide and ribozyme design.
    Probst JC
    Methods; 2000 Nov; 22(3):271-81. PubMed ID: 11071823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo-cyclic oligonucleotides: in vitro and in vivo properties.
    Jiang Z; Kandimalla ER; Zhao Q; Shen LX; DeLuca A; Normano N; Ruskowski M; Agrawal S
    Bioorg Med Chem; 1999 Dec; 7(12):2727-35. PubMed ID: 10658577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antisense effect of PEGylated oligodeoxynucleotides containing intelligent nucleoside analogues.
    Taniguchi Y; Kurose Y; Nishioka T; Nagatsugi F; Sasaki S
    Nucleic Acids Symp Ser (Oxf); 2009; (53):167-8. PubMed ID: 19749313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological properties of DNA-peptide conjugates.
    Kubo T; Yokoyama K; Sasaki K; Dubey KK; Fujii M
    Nucleic Acids Res Suppl; 2001; (1):75-6. PubMed ID: 12836271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense-induced Fas mRNA degradation produces site-specific stable 3'-mRNA fragment by exonuclease cleavage at the complementary sequence.
    Thonberg H; Dahlgren C; Wahlestedt C
    Oligonucleotides; 2004; 14(3):221-6. PubMed ID: 15625917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational selection of antisense oligonucleotide sequences.
    Smith L; Andersen KB; Hovgaard L; Jaroszewski JW
    Eur J Pharm Sci; 2000 Sep; 11(3):191-8. PubMed ID: 11042224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense activity detection by inhibition of fluorescence resonance energy transfer.
    Benítez-Hess ML; DiPaolo JA; Alvarez-Salas LM
    Luminescence; 2004; 19(2):85-93. PubMed ID: 15098208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic transfectors increase accumulation in cultured tumor cells of radiolabeled antisense DNAs without entrapment.
    Nakamura K; Wang Y; Liu X; Kubo A; Hnatowich DJ
    Cancer Biother Radiopharm; 2007 Oct; 22(5):629-35. PubMed ID: 17979565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.